Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Assessing blood samples with new device pinpoints early warning signs for COVID-19 patients

The researchers found an unusually high amount of platelet aggregation in patient samples, a known indicator of microvascular thrombosis.

vaccine syringe covid-19 coronavirus

FDA expands Pfizer booster shots to 16- and 17-year-olds

The emergency authorization paves the way for millions of younger adults to get a third dose of the vaccine.

‘Potentially big impact’: New ingredient praised as possible solution for better COVID-19 vaccines

Early experiments showed the saponin/TLR adjuvant activates many different parts of the immune system to strengthen its response against invading pathogens.

30% of healthcare workers in U.S. hospitals are unvaccinated, large-scale analysis reveals

Those involved in the CDC-led study say it's the most comprehensive analysis of its kind.

Pfizer formally submits COVID-19 pill to FDA for emergency use authorization

An initial analysis revealed Paxlovid reduced the risk of hospitalization or death in high-risk patients who took the pill within 3 days of experiencing symptoms.

Thumbnail

40% of providers plan to keep COVID-19 protocols in place post-pandemic

Additionally, 71% of medical professionals said safety standards increased during the health crisis.

FDA recalls 2.2M at-home COVID tests due to false positive results

Ellume was the first company to gain federal authorization for an over-the-counter test to detect COVID-19.

coronavirus COVID-19 vaccine vaccination

COVID-19 vaccines are less effective on the immunocompromised

These individuals are less likely to benefit from COVID-19 vaccines, according to a recent study from the Centers for Disease Control and Prevention.

Around the web

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel.